Boosting a neuronal protein could slow aging and fight neurodegeneration, study suggests
A groundbreaking study identifies a new therapeutic strategy for neurodegenerative diseases by boosting a protein called PI31, which is essential for delivering the brain’s protein-cleansing machinery to the synapses where neurons communicate. In fruit flies and mice, increasing PI31 levels prevented neuronal degeneration, reversed motor problems, and, in some cases, extended lifespan by nearly four times. The research challenges the long-running amyloid hypothesis that has guided Alzheimer’s and related disease research for decades and proposes that early synaptic dysfunction and impaired protein clearance—not plaques alone—may drive brain aging. For Thai readers, the findings arrive at a moment when aging populations and rising dementia concerns are reshaping healthcare planning, caregiver burdens, and the cultural conversation around aging with dignity.